Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies

BACKGROUND: Smoking is a major risk factor for COPD and may impact the efficacy of COPD treatments; however, a large proportion of COPD patients continue to smoke following diagnosis. METHODS: This post-hoc analysis of pooled data from the replicate 12-week, placebo-controlled GEM1 and GEM2 studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P., Goodin, Thomas, Bowling, Alyssa, Price, Barry, Ozol-Godfrey, Ayca, Sharma, Sanjay, Sanjar, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604131/
https://www.ncbi.nlm.nih.gov/pubmed/31266489
http://dx.doi.org/10.1186/s12931-019-1112-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604131/
https://www.ncbi.nlm.nih.gov/pubmed/31266489
http://dx.doi.org/10.1186/s12931-019-1112-0

Ejemplares similares